Cargando…

Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuetz, Johanna M, MacArthur, Amy C, Leach, Stephen, Lai, Agnes S, Gallagher, Richard P, Connors, Joseph M, Gascoyne, Randy D, Spinelli, John J, Brooks-Wilson, Angela R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788526/
https://www.ncbi.nlm.nih.gov/pubmed/19917125
http://dx.doi.org/10.1186/1471-2350-10-117
_version_ 1782174987798446080
author Schuetz, Johanna M
MacArthur, Amy C
Leach, Stephen
Lai, Agnes S
Gallagher, Richard P
Connors, Joseph M
Gascoyne, Randy D
Spinelli, John J
Brooks-Wilson, Angela R
author_facet Schuetz, Johanna M
MacArthur, Amy C
Leach, Stephen
Lai, Agnes S
Gallagher, Richard P
Connors, Joseph M
Gascoyne, Randy D
Spinelli, John J
Brooks-Wilson, Angela R
author_sort Schuetz, Johanna M
collection PubMed
description BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1 (MRN) complex and BLM have central roles in maintenance of DNA integrity. Severe mutations in any of these genes cause genetic disorders, some of which are characterized by increased risk of lymphoma. METHODS: We surveyed the genetic variation in these genes in constitutional DNA of NHL patients by means of gene re-sequencing, then conducted genetic association tests for susceptibility to NHL in a population-based collection of 797 NHL cases and 793 controls. RESULTS: 114 SNPs were discovered in our sequenced samples, 61% of which were novel and not previously reported in dbSNP. Although four variants, two in RAD50 and two in NBS1, showed association results suggestive of an effect on NHL, they were not significant after correction for multiple tests. CONCLUSION: These results suggest an influence of RAD50 and NBS1 on susceptibility to diffuse large B-cell lymphoma and marginal zone lymphoma. Larger association and functional studies could confirm such a role.
format Text
id pubmed-2788526
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27885262009-12-04 Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma Schuetz, Johanna M MacArthur, Amy C Leach, Stephen Lai, Agnes S Gallagher, Richard P Connors, Joseph M Gascoyne, Randy D Spinelli, John J Brooks-Wilson, Angela R BMC Med Genet Research article BACKGROUND: Translocations are hallmarks of non-Hodgkin lymphoma (NHL) genomes. Because lymphoid cell development processes require the creation and repair of double stranded breaks, it is not surprising that disruption of this type of DNA repair can cause cancer. The members of the MRE11-RAD50-NBS1 (MRN) complex and BLM have central roles in maintenance of DNA integrity. Severe mutations in any of these genes cause genetic disorders, some of which are characterized by increased risk of lymphoma. METHODS: We surveyed the genetic variation in these genes in constitutional DNA of NHL patients by means of gene re-sequencing, then conducted genetic association tests for susceptibility to NHL in a population-based collection of 797 NHL cases and 793 controls. RESULTS: 114 SNPs were discovered in our sequenced samples, 61% of which were novel and not previously reported in dbSNP. Although four variants, two in RAD50 and two in NBS1, showed association results suggestive of an effect on NHL, they were not significant after correction for multiple tests. CONCLUSION: These results suggest an influence of RAD50 and NBS1 on susceptibility to diffuse large B-cell lymphoma and marginal zone lymphoma. Larger association and functional studies could confirm such a role. BioMed Central 2009-11-16 /pmc/articles/PMC2788526/ /pubmed/19917125 http://dx.doi.org/10.1186/1471-2350-10-117 Text en Copyright ©2009 Schuetz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Schuetz, Johanna M
MacArthur, Amy C
Leach, Stephen
Lai, Agnes S
Gallagher, Richard P
Connors, Joseph M
Gascoyne, Randy D
Spinelli, John J
Brooks-Wilson, Angela R
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title_full Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title_fullStr Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title_full_unstemmed Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title_short Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
title_sort genetic variation in the nbs1, mre11, rad50 and blm genes and susceptibility to non-hodgkin lymphoma
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788526/
https://www.ncbi.nlm.nih.gov/pubmed/19917125
http://dx.doi.org/10.1186/1471-2350-10-117
work_keys_str_mv AT schuetzjohannam geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT macarthuramyc geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT leachstephen geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT laiagness geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT gallagherrichardp geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT connorsjosephm geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT gascoynerandyd geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT spinellijohnj geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma
AT brookswilsonangelar geneticvariationinthenbs1mre11rad50andblmgenesandsusceptibilitytononhodgkinlymphoma